Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 2d ago.
Showing the 49 most recent target moves over 90 days.
| Maintained |
| Neutral |
| $55 $80 |
| Aug 20 |
| KNSAKiniksa Pharmaceuticals International, plc | Wedbush | Maintained | Outperform | $72 $99 | Jul 29 |
| ABNBAirbnb, Inc. | Wedbush | Upgraded from Neutral | Outperform | $152 $200 | Aug 7 |
| SYRESpyre Therapeutics, Inc. | Wedbush | Maintained | Outperform | $100 $130 | Aug 5 |
| EXPEExpedia Group, Inc. | Wedbush | Maintained | Outperform | $334 $417 | Aug 20 |
| STXSeagate Technology Holdings plc | Wedbush | Maintained | Outperform | $825 $1,000 | Jul 29 |
| SIONSionna Therapeutics, Inc. | Wedbush | Maintained | Neutral | $5 $6 | Sep 15 |
| RBLXRoblox Corporation | Wedbush | Maintained | Neutral | $40 $48 | Sep 14 |
| SMCISuper Micro Computer, Inc. | Wedbush | Maintained | Neutral | $34 $40 | Aug 12 |
| BKNGBooking Holdings Inc. | Wedbush | Maintained | Outperform | $211 $247 | Aug 5 |
| COAGHemab Therapeutics Holdings, Inc. | Wedbush | Maintained | Outperform | $55 $64 | Aug 12 |
| DNTHDianthus Therapeutics, Inc. | Wedbush | Maintained | Outperform | $105 $122 | Aug 5 |
| RBLXRoblox Corporation | Wedbush | Maintained | Neutral | $48 $55 | 2d ago |
| IRONDisc Medicine, Inc. | Wedbush | Maintained | Outperform | $88 $100 | Sep 2 |
| SHOPShopify Inc. | Wedbush | Maintained | Outperform | $155 $176 | Aug 6 |
| NTAPNetApp, Inc. | Wedbush | Maintained | Neutral | $150 $170 | Sep 3 |
| ZSZscaler, Inc. | Wedbush | Maintained | Outperform | $215 $240 | Oct 7 |
| IRONDisc Medicine, Inc. | Wedbush | Maintained | Outperform | $100 $110 | 5d ago |
| ARGXargenx SE | Wedbush | Maintained | Outperform | $1,050 $1,150 | Aug 18 |
| METAMeta Platforms, Inc. | Wedbush | Maintained | Neutral | $595 $650 | Sep 14 |
| NTLAIntellia Therapeutics, Inc. | Wedbush | Maintained | Neutral | $12 $13 | Sep 9 |
| DUOLDuolingo, Inc. | Wedbush | Maintained | Neutral | $139 $150 | Aug 20 |
| SOLVSolventum Corporation | Wedbush | Maintained | Outperform | $94 $101 | Aug 6 |
| DASHDoorDash, Inc. | Wedbush | Maintained | Neutral | $205 $220 | Aug 20 |
| BIIBBiogen Inc. | Wedbush | Maintained | Neutral | $201 $215 | Jul 30 |
| BNTCBenitec Biopharma Inc. | Wedbush | Maintained | Outperform | $16 $17 | Sep 15 |
| AMZNAmazon.com, Inc. | Wedbush | Maintained | Outperform | $293 $310 | Jul 31 |
| VRSNVeriSign, Inc. | Wedbush | Maintained | Outperform | $324 $341 | Sep 1 |
| ARGXargenx SE | Wedbush | Maintained | Outperform | $1,000 $1,050 | Jul 28 |
| NVDANVIDIA Corporation | Wedbush | Maintained | Outperform | $330 $345 | Aug 27 |
| METAMeta Platforms, Inc. | Wedbush | Maintained | Neutral | $700 $730 | 3d ago |
| CBRSCerebras Systems Inc. | Wedbush | Maintained | Outperform | $280 $290 | Aug 13 |
| VRSNVeriSign, Inc. | Wedbush | Maintained | Outperform | $341 $351 | 6d ago |
| EBAYeBay Inc. | Wedbush | Maintained | Outperform | $135 $137 | Aug 20 |
| APPAppLovin Corporation | Wedbush | Maintained | Outperform | $640 $610 | Aug 6 |
| BCRXBioCryst Pharmaceuticals, Inc. | Wedbush | Maintained | Outperform | $21 $20 | Aug 6 |
| SYRESpyre Therapeutics, Inc. | Wedbush | Maintained | Outperform | $130 $123 | Aug 26 |
| APPAppLovin Corporation | Wedbush | Maintained | Outperform | $610 $560 | Oct 14 |
| FLTR.L | Wedbush | Maintained | Outperform | $138 $126 | Aug 6 |
| NFLXNetflix, Inc. | Wedbush | Maintained | Outperform | $90 $80 | 4d ago |
| METAMeta Platforms, Inc. | Wedbush | Maintained | Neutral | $671 $595 | Jul 30 |
| RDDTReddit, Inc. | Wedbush | Maintained | Outperform | $250 $221 | Jul 31 |
| NFLXNetflix, Inc. | Wedbush | Maintained | Outperform | $105 $90 | Oct 16 |
| GDDYGoDaddy Inc. | Wedbush | Maintained | Outperform | $109 $93 | Aug 3 |
| VERAVera Therapeutics, Inc. | Wedbush | Maintained | Neutral | $43 $34 | Aug 11 |
| RBLXRoblox Corporation | Wedbush | Downgraded from Outperform | Neutral | $65 $40 | Jul 31 |
| SIONSionna Therapeutics, Inc. | Wedbush | Downgraded from Outperform | Neutral | $53 $5 | Aug 11 |